three of these selected compounds , pyrazofurin ( pyrazomycin ) , ribavirin ( virazole ) , and 9-beta-d-arabinofuranosyladenine ( ara-a ) , produced a significant ( 50 % -100 % ) inhibition of virus-induced splenomegaly development in mice , whereas the other two candidate inhibitors , 3-deazauridine ( deazaur ) and rifamycin sv , the other two candidate inhibitors , 3-deazauridine ( deazaur ) and rifamycin sv , failed to demonstrate any in vivo activity in this 21-day leukemogenesis assay .
C0035525
ribavirin
C1622085
virazole